Delivery Order SPE2DB24D1205-SPE2DB25FCZMQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,204.42 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 ml auto-injector units on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy medication delivered via auto-injector,...
- The Defense Logistics Agency awarded a $1,760.63 delivery order to AmerisourceBergen Drug Corp on May 21, 2025, for XYOSTED 75 mg/0.5 ml auto-injector supplies. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of May 22, 2025. XYOSTED is a testosterone replacement therapy medication delivered via auto-injector, supporting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $3,706.98 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 mL auto-injector supplies on September 10, 2025, with completion targeted for September 11, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product delivered via...
- The Defense Logistics Agency awarded a delivery order valued at $3,508.98 to AmerisourceBergen Drug Corp for XYOSTED 50 MG/0.5 ML auto-injector units on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy medication delivered via...
- The Defense Logistics Agency awarded a delivery order valued at $3,816.88 to AmerisourceBergen Drug Corp for XYOSTED 100 MG/0.5 ML auto-injector supplies. This non-set-aside, firm fixed-price delivery order was executed on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product used in the treatment of hormone deficiency, representing part of the...
- The Defense Logistics Agency awarded a delivery order valued at $5,138.67 to AmerisourceBergen Drug Corp for XYOSTED 50 MG/0.5 ML auto-injector supplies on July 14, 2025, with completion scheduled for July 15, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product used to treat hypogonadism in males, and this order...
- The Defense Logistics Agency awarded a delivery order valued at $9,864.56 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 ml auto-injector supplies. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by August 11, 2025. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product delivered via auto-injector, supporting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $3,659.06 to AmerisourceBergen Drug Corp for XYOSTED 75 mg/0.5 mL auto-injector supplies on August 4, 2025, with completion targeted for August 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. XYOSTED is a testosterone replacement therapy auto-injector used in military and federal healthcare systems to...
- The Defense Logistics Agency awarded a delivery order valued at $1,248.08 to AmerisourceBergen Drug Corp for Xyosted 100 mg/0.5 mL auto-injectors on August 22, 2025, with completion targeted for August 25, 2025. This firm fixed-price contract represents a non-set-aside competitive award and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injector, addressing pharmaceutical...
- The Defense Logistics Agency awarded a $1,937.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xyosted 75 mg/0.5 mL auto-injector supplies. This competitively awarded, non-set-aside contract was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Xyosted is a testosterone replacement therapy product delivered via auto-injector, supporting the military...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZMQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,334.76 to AmerisourceBergen Drug Corp for XYOSTED 100 mg/0.5 ml auto-injector supplies, with an ultimate completion date of August 14, 2025. This non-competitive, firm fixed-price delivery order was issued on August 13, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. XYOSTED is a testosterone replacement therapy product delivered via subcutaneous auto-injector, and this procurement supports federal medical supply needs for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an enterprise-wide pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal medical supply contracts covering a broad range of therapeutic domains, including specialty medications, vaccines, and medical devices. The SPE2DX vehicle enables the contractor to provide comprehensive pharmaceutical support across multiple service branches and federal healthcare agencies on a global basis, with firm fixed pricing applied to individual delivery orders such as this one.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/13/25 |